HomeCompareMRVFF vs PLD

MRVFF vs PLD: Dividend Comparison 2026

MRVFF yields 204.19% · PLD yields 3.10%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRVFF wins by $128.73M in total portfolio value
10 years
MRVFF
MRVFF
● Live price
204.19%
Share price
$0.98
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$134.64M
Annual income
$68,573,578.28
Full MRVFF calculator →
PLD
PLD
● Live price
3.10%
Share price
$132.18
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5.91M
Annual income
$4,750,725.19
Full PLD calculator →

Portfolio growth — MRVFF vs PLD

📍 MRVFF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMRVFFPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MRVFF + PLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MRVFF pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MRVFF
Annual income on $10K today (after 15% tax)
$17,355.79/yr
After 10yr DRIP, annual income (after tax)
$58,287,541.54/yr
PLD
Annual income on $10K today (after 15% tax)
$263.66/yr
After 10yr DRIP, annual income (after tax)
$4,038,116.41/yr
At 15% tax rate, MRVFF beats the other by $54,249,425.13/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MRVFF + PLD for your $10,000?

MRVFF: 50%PLD: 50%
100% PLD50/50100% MRVFF
Portfolio after 10yr
$70.27M
Annual income
$36,662,151.73/yr
Blended yield
52.17%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

MRVFF
No analyst data
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+2.9% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MRVFF buys
0
PLD buys
0
No recent congressional trades found for MRVFF or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMRVFFPLD
Forward yield204.19%3.10%
Annual dividend / share$2.00$4.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%74.4%
Portfolio after 10y$134.64M$5.91M
Annual income after 10y$68,573,578.28$4,750,725.19
Total dividends collected$127.03M$5.78M
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: MRVFF vs PLD ($10,000, DRIP)

YearMRVFF PortfolioMRVFF Income/yrPLD PortfolioPLD Income/yrGap
1← crossover$31,119$20,418.58$11,241$540.96+$19.9KMRVFF
2$92,680$59,382.92$13,019$991.13+$79.7KMRVFF
3$264,456$165,288.68$15,801$1,870.97+$248.7KMRVFF
4$723,754$440,785.96$20,609$3,701.21+$703.1KMRVFF
5$1,901,825$1,127,408.73$29,919$7,867.97+$1.87MMRVFF
6$4,803,662$2,768,709.08$50,631$18,617.74+$4.75MMRVFF
7$11,675,668$6,535,748.92$105,528$51,352.20+$11.57MMRVFF
8$27,339,353$14,846,388.95$287,364$174,449.42+$27.05MMRVFF
9$61,742,649$32,489,540.64$1,081,760$774,280.77+$60.66MMRVFF
10$134,638,212$68,573,578.28$5,908,209$4,750,725.19+$128.73MMRVFF

MRVFF vs PLD: Complete Analysis 2026

MRVFFStock

Nuvo Pharmaceuticals Inc., doing business as Miravo Healthcare, provides prescription and non-prescription products for pain, allergy, neurology, and dermatology worldwide. The company operates in three segments: Commercial Business, Production and Service Business, and Licensing and Royalty Business. It offers Blexten, an antihistamine drug for the symptomatic relief of allergic rhinitis and chronic spontaneous urticaria; Cambia, a nonsteroidal anti-inflammatory drug for migraine; Suvexx/Treximet, a migraine medicine; NeoVisc, an injectable viscosupplement for osteoarthritis; and Resultz, FullMarks, and LAUSBUB for head lice infestations. The company also provides Bezalip SR for patients with high cholesterol or high levels of triglycerides; Proferrin, an iron supplement for the prevention and treatment of iron deficiency; Fiorinal 1 and Fiorinal C1 for the relief of tension-type headaches; Collatamp G for surgical implantation during surgery; PegaLAX, a laxative for the treatment of occasional constipation and irregularity; Mutaflor, a probiotic for the management and relief of chronic constipation and associated abdominal pain and cramps; MoviPrep for the cleansing of the colon in preparation for colonoscopy; and Soriatane to treat psoriasis and other keratinization disorders. In addition, it offers Pennsaid and Pennsaid 2% topical treatments for osteoarthritic pain; Vimovo for relief of arthritis symptoms; SYNERA and RAPYDAN topical patches used to help prevent pain associated with needle sticks and other superficial skin procedures; Yosprala for the prevention of heart attacks and strokes; and Heated Lidocaine/Tetracaine Patch, a topical patch applied prior to painful medical procedures. The company was formerly known as Nuvo Research Inc. and changed its name to Nuvo Pharmaceuticals Inc. in March 2016. Nuvo Pharmaceuticals Inc. was incorporated in 1983 and is headquartered in Mississauga, Canada.

Full MRVFF Calculator →

PLDREIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →
📬

Get this MRVFF vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MRVFF vs SCHDMRVFF vs JEPIMRVFF vs OMRVFF vs KOMRVFF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.